Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
Publication
, Journal Article
Becker, RC; Scheiman, J; Dauerman, HL; Spencer, F; Rao, S; Sabatine, M; Johnson, DA; Chan, F; Abraham, NS; Quigley, EMM ...
Published in: Am J Gastroenterol
December 2009
The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.
Duke Scholars
Published In
Am J Gastroenterol
DOI
EISSN
1572-0241
Publication Date
December 2009
Volume
104
Issue
12
Start / End Page
2903 / 2917
Location
United States
Related Subject Headings
- Thrombolytic Therapy
- Stents
- Risk Management
- Risk Factors
- Risk Assessment
- Practice Guidelines as Topic
- Platelet Aggregation Inhibitors
- Humans
- Hemorrhage
- Graft Occlusion, Vascular
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C., Scheiman, J., Dauerman, H. L., Spencer, F., Rao, S., Sabatine, M., … American College of Cardiology and the American College of Gastroenterology, . (2009). Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol, 104(12), 2903–2917. https://doi.org/10.1038/ajg.2009.667
Becker, Richard C., James Scheiman, Harold L. Dauerman, Frederick Spencer, Sunil Rao, Marc Sabatine, David A. Johnson, et al. “Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.” Am J Gastroenterol 104, no. 12 (December 2009): 2903–17. https://doi.org/10.1038/ajg.2009.667.
Becker RC, Scheiman J, Dauerman HL, Spencer F, Rao S, Sabatine M, et al. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol. 2009 Dec;104(12):2903–17.
Becker, Richard C., et al. “Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.” Am J Gastroenterol, vol. 104, no. 12, Dec. 2009, pp. 2903–17. Pubmed, doi:10.1038/ajg.2009.667.
Becker RC, Scheiman J, Dauerman HL, Spencer F, Rao S, Sabatine M, Johnson DA, Chan F, Abraham NS, Quigley EMM, American College of Cardiology and the American College of Gastroenterology. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol. 2009 Dec;104(12):2903–2917.
Published In
Am J Gastroenterol
DOI
EISSN
1572-0241
Publication Date
December 2009
Volume
104
Issue
12
Start / End Page
2903 / 2917
Location
United States
Related Subject Headings
- Thrombolytic Therapy
- Stents
- Risk Management
- Risk Factors
- Risk Assessment
- Practice Guidelines as Topic
- Platelet Aggregation Inhibitors
- Humans
- Hemorrhage
- Graft Occlusion, Vascular